Kan AI udvikle et system, der kan redigere menneskelige embryoner for at eliminere genetiske sygdomme og forbedre intelligens ved hjælp af CRISPR og AI-styret design ?
Afgiv din stemme — læs så hvad vores redaktør og AI-modellerne fandt.
AI assisterer allerede ved CRISPR-gene-redigering, men det næste spring ville være autonom design af redigeringer, der garanterer både sundhedsforbedringer og IQ-gevinster. Regulatoriske og etiske barrierer består fortsat, men teknisk gennemførlighed nærmer sig.
Background
Current AI tools can predict how CRISPR edits will change DNA sequences and suggest optimal guide RNAs to cut at specific sites, but they cannot reliably design edits that are guaranteed to eliminate polygenic diseases like diabetes or Alzheimer’s while avoiding off-target effects or unintended edits elsewhere in the genome. No AI system today can predict how hundreds or thousands of genetic changes would reliably enhance intelligence in a human embryo, because intelligence is a highly polygenic trait influenced by environmental factors, and current models cannot model developmental pathways or long-term outcomes. Germline editing in humans remains strictly regulated or banned in most countries. Ethical guidelines from the WHO and national academies advise against heritable human genome editing beyond preventing serious monogenic diseases. While AI has made significant progress in genome editing and CRISPR design, the development of a system that can safely and effectively edit human embryos to eliminate genetic diseases and enhance intelligence is still in its infancy. Current AI-guided CRISPR systems can identify potential targets for editing, but the complexity of the human genome and the need for precise control over the editing process pose significant challenges. Additionally, the ethical and regulatory considerations surrounding human embryo editing are still being debated and have not been fully resolved. As a result, the use of AI-guided CRISPR for human embryo editing is still largely experimental and not yet ready for clinical application.
Foreslå et tag
Mangler et begreb i dette emne? Foreslå det, admin gennemgår.
Status senest tjekket September 24, 2026.
Galleri
Kan AI udvikle et system, der kan redigere menneskelige embryoner for at eliminere genetiske sygdomme og forbedre intelligens ved hjælp af CRISPR og AI-styret design?
Uden for AI's rækkevidde indtil videre. Kapacitetskløften er reel.
But the data is real.
The Case File
Across 27 sessions, 54 jurors have heard this case. Combined tally: 0 YES · 29 ALMOST · 23 NO · 2 IN RESEARCH.
Note: cumulative includes older juror opinions. The current session tally above is the live verdict.
By a vote of 0 — 0 — 1, the panel returns a verdict of NEJ, with verdict confidence of 95%. The court so orders.
"No AI system has reliably edited human embryos for disease elimination or intelligence enhancement."
Individuelle nævningers udtalelser vises på originalengelsk for at bevare bevismæssig præcision.
Hvad publikum mener
Nej 46% · Ja 31% · Måske 23% 26 votesDiskussion
no comments⚖ 27 jury checks · seneste for 3 dage siden
Hver række er et separat jurytjek. Nævninger er AI-modeller (identiteter holdt neutrale med vilje). Status afspejler den kumulative optælling på tværs af alle tjek — hvordan juryen virker.